After spending much of the year sloping steadily downward from a January peak, TV drug ad spending picked up in a major way ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion ...

As the prospect of import tariffs and drug price reform marshals billions of biopharma investment dollars into the U.S., the ...

Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung ...

Through the five-year initiative, the Merck Foundation will provide grants to 11 organizations working to improve health outcomes in places where timely access to cardiovascular care is a challenge.

Eli Lilly expanded its AI drug discovery pact with XtalPi to antibodies. Celltrion in-licensed two innovative autoimmune ...

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...